High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis (Q38389634)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 July 2016
edit
Language Label Description Also known as
English
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
scientific article published on 22 July 2016

    Statements

    High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis (English)
    Humberto Aguilar
    Benedict Maliakkal
    Federico J Mensa

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit